# Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia

> **NCT05397262** · NA · RECRUITING · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 1000 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **OTHER:** Hyperthermia
- **RADIATION:** Radiotherapy
- **DRUG:** Chemotherapy 5-Fluorouracil
- **DRUG:** Chemotherapy Cisplatin

## Key facts

- **NCT ID:** NCT05397262
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-03-29
- **Primary completion:** 2098-12-31
- **Final completion:** 2099-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05397262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05397262, "Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05397262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*